Comparing the effectiveness of two psychological treatments in leukemia

Determining the effectiveness and comparison of cognitive behavioral therapy and acceptance and receptivity therapy on pain perception and self-efficacy in coping with cancer in patients with leukemia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250902067091N1

Enrollment

Registered

2025-09-10

Start date

2025-09-23

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Chronic myeloid leukaemia. Condition 2: Chronic lymphocytic leukaemia. Chronic myeloid leukemia, BCR/ABL-positive Chronic lymphocytic leukemia of B-cell type

Interventions

Intervention 1: The first intervention group: This group will receive cognitive behavioral therapy for ten sessions, one session per week for one hour. Intervention 2: The second intervention group: T

Eligibility

Sex/Gender

All

Age

30 Years to 50 Years

Inclusion criteria

Inclusion criteria: Diagnosis of chronic myeloid and lymphoid leukemia Having at least a cycle of education Age between 30 and 50 years Consent to participate in the project

Exclusion criteria

Exclusion criteria: Receiving psychiatric medications and psychotherapy Having other acute or chronic mental and physical disorders

Design outcomes

Primary

Measure	Time frame
Pain perception: In the present study, pain perception refers to the score that participants obtained on the McGill Pain Questionnaire (1997). Pain perception is defined as an unpleasant sensory and emotional experience associated with actual or potential tissue damage. Timepoint: Before the start of the intervention (pre-test) and immediately after the intervention (post-test) and in the follow-up phase 3 months after the intervention. Method of measurement: McGill pain questionnaire.;Self-efficacy in coping with cancer: It is the score that participants obtained in the Cancer Behavior Inventory (Hitzman et al.). Self-efficacy in coping with cancer refers to an individual's confidence in facing challenges arising from cancer-related events. Timepoint: Before the start of the intervention (pre-test) and immediately after the intervention (post-test) and in the follow-up phase 3 months after the intervention. Method of measurement: Cancer Behavior Inventory.	—

Measure

Time frame

Pain perception: In the present study, pain perception refers to the score that participants obtained on the McGill Pain Questionnaire (1997). Pain perception is defined as an unpleasant sensory and emotional experience associated with actual or potential tissue damage. Timepoint: Before the start of the intervention (pre-test) and immediately after the intervention (post-test) and in the follow-up phase 3 months after the intervention. Method of measurement: McGill pain questionnaire.;Self-efficacy in coping with cancer: It is the score that participants obtained in the Cancer Behavior Inventory (Hitzman et al.). Self-efficacy in coping with cancer refers to an individual's confidence in facing challenges arising from cancer-related events. Timepoint: Before the start of the intervention (pre-test) and immediately after the intervention (post-test) and in the follow-up phase 3 months after the intervention. Method of measurement: Cancer Behavior Inventory.

—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactmaya zakizadeh

Islamic Azad University

maya.zakizade@iau.ac.ir+98 26 3270 8641

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026